Stay updated on Vilazodone Safety in GAD: Clinical Trial
Sign up to get notified when there's something new on the Vilazodone Safety in GAD: Clinical Trial page.

Latest updates to the Vilazodone Safety in GAD: Clinical Trial page
- Check4 days agoChange DetectedThe page’s footer revision label has been updated from v3.5.2 to v3.5.3, indicating a minor site/version update without changing the study content.SummaryDifference0.0%

- Check11 days agoChange DetectedPage revision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check40 days agoChange DetectedSite revision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check47 days agoChange DetectedRevision: v3.4.3 was added and the previous Revision: v3.4.2 was removed in the page header.SummaryDifference0.0%

- Check76 days agoChange DetectedMaintenance updates: added Revision: v3.4.2 and removed the funding status notice and prior Revision v3.4.1; these changes do not affect study content or user actions. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check83 days agoChange DetectedA site-wide government funding notice has been added, noting that the NIH Clinical Center is open and directing users to cc.nih.gov, and the page shows a new revision tag (v3.4.1) replacing v3.4.0.SummaryDifference0.3%

Stay in the know with updates to Vilazodone Safety in GAD: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Vilazodone Safety in GAD: Clinical Trial page.